UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia

The American journal of psychiatry, 2017-05, Vol.174 (5), p.476-484

2017

Volltextzugriff (PDF)

The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study

The journal of clinical psychiatry, 2017-11, Vol.78 (9), p.1344-1350

2017

Volltextzugriff (PDF)

A long-term, open-label study of valbenazine for tardive dyskinesia

CNS spectrums, 2021-08, Vol.26 (4), p.345-353

2021

Volltextzugriff (PDF)

Single-Dose Study of a Corticotropin-Releasing Factor Receptor-1 Antagonist in Women With 21-Hydroxylase Deficiency

The journal of clinical endocrinology and metabolism, 2016-03, Vol.101 (3), p.1174-1180

2016

Volltextzugriff (PDF)

Characterizing Treatment Effects of Valbenazine for Tardive Dyskinesia: Additional Results from the KINECT 3 Study

The journal of clinical psychiatry, 2018-12, Vol.80 (1)

2018

Volltextzugriff (PDF)

NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study

Movement disorders, 2015-10, Vol.30 (12), p.1681-1687

2015

Volltextzugriff (PDF)

Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference

Movement disorders, 2019-08, Vol.34 (8), p.1203-1209

2019

Volltextzugriff (PDF)

Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials

Drug safety, 2018-04, Vol.41 (4), p.429-440

2018

Volltextzugriff (PDF)

Development and Validation of the Endometriosis Daily Pain Impact Diary Items to Assess Dysmenorrhea and Nonmenstrual Pelvic Pain

Reproductive sciences (Thousand Oaks, Calif.), 2018-11, Vol.25 (11), p.1567-1576

2018

Volltextzugriff (PDF)

A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia

Journal of clinical psychopharmacology, 2019-11, Vol.39 (6), p.620-627

2019

Volltextzugriff (PDF)

Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine

Drugs in R&D, 2017-09, Vol.17 (3), p.449-459

2017

Volltextzugriff (PDF)

Clozapine use in Parkinson's disease: A retrospective analysis of a large multicentered clinical experience

Movement disorders, 1998-05, Vol.13 (3), p.377-382

1998

Volltextzugriff (PDF)

Treatment of Spasticity With Botulinum Toxin

The Clinical journal of pain, 2002-11, Vol.18 (6 Suppl), p.S182-S190

OʼBrien, Christopher F

2002

Volltextzugriff (PDF)

Pharmacokinetics of Valbenazine and Its Active Metabolite by Age Group

The American journal of geriatric psychiatry, 2018-03, Vol.26 (3), p.S159

2018

Volltextzugriff (PDF)

Poster Number: NR 31 - Pharmacokinetics of Valbenazine and Its Active Metabolite by Age Group

The American journal of geriatric psychiatry, 2018-03, Vol.26 (3), p.S159-S159

2018

Volltextzugriff (PDF)

The Estimated Cost of Managing Focal Spasticity: A Physician Practice Patterns Survey

Neurorehabilitation and neural repair, 2001-01, Vol.15 (1), p.57-68

2001

Volltextzugriff (PDF)

A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia

Clinical neuropharmacology, 2000-03, Vol.23 (2), p.75-81

2000

Volltextzugriff (PDF)

Single Dose and Repeat Once-Daily Dose Safety, Tolerability and Pharmacokinetics of Valbenazine in Healthy Male Subjects

Psychopharmacology bulletin, 2017-08, Vol.47 (3), p.44-52

2017

Volltextzugriff (PDF)

Injection techniques for botulinum toxin using electromyography and electrical stimulation

Muscle & nerve, 1997, Vol.20 (S6), p.176-180

O'Brien, Christopher F.

1997

Volltextzugriff (PDF)

Treatment of spasticity with botulinum toxin: Botulinum toxin for pain management and other medical conditions: a comprehensive review

The Clinical journal of pain, 2002, Vol.18 (6), p.S182-S190

O'BRIEN, Christopher F

2002

Volltextzugriff (PDF)

Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder

Psychopharmacology bulletin, 2017-08, Vol.47 (3), p.69-76

2017

Volltextzugriff (PDF)

Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder

Psychopharmacology bulletin, 2017-08, Vol.47 (3), p.61-68

2017

Volltextzugriff (PDF)

Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder

Psychopharmacology bulletin, 2017-08, Vol.47 (3), p.53-60

2017

Volltextzugriff (PDF)

N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease

Archives of neurology (Chicago), 1991-09, Vol.48 (9), p.977-981

1991

Volltextzugriff (PDF)

Spasticity after stroke. Epidemiology and optimal treatment

Drugs & aging, 1996-11, Vol.9 (5), p.332-340

1996

Volltextzugriff (PDF)

1 – 25 von 450

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(415)
Mit Volltextzugriff
(372)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(330)
Life Sciences & Biomedicine
(275)
Humans
(233)
Female
(139)
Male
(133)
Middle Aged
(102)
Aged
(89)
Adult
(80)
Biological And Medical Sciences
(78)
Medical Sciences
(70)
Neurosciences & Neurology
(51)
Clinical Neurology
(43)
Treatment Outcome
(42)
Aged, 80 And Over
(38)
Cardiovascular System & Cardiology
(38)
Surgery
(31)
Adolescent
(30)
General & Internal Medicine
(30)
Risk Factors
(30)
Science & Technology - Other Topics
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Spine Journal
(13)
Journal Of The American College Of Cardiology
(9)
Nature Communications
(9)
Alzheimer's & Dementia
(8)
Nature
(8)
Blood
(7)
Science
(7)
Cancer
(6)
Neurology
(6)
The New England Journal Of Medicine
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia

The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study

A long-term, open-label study of valbenazine for tardive dyskinesia

Single-Dose Study of a Corticotropin-Releasing Factor Receptor-1 Antagonist in Women With 21-Hydroxylase Deficiency

Characterizing Treatment Effects of Valbenazine for Tardive Dyskinesia: Additional Results from the KINECT 3 Study

NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study

Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference

Cardiovascular Profile of Valbenazine: Analysis of Pooled Data from Three Randomized, Double-Blind, Placebo-Controlled Trials

Development and Validation of the Endometriosis Daily Pain Impact Diary Items to Assess Dysmenorrhea and Nonmenstrual Pelvic Pain

A Phase 3, 1-Year, Open-Label Trial of Valbenazine in Adults With Tardive Dyskinesia

Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine

Clozapine use in Parkinson's disease: A retrospective analysis of a large multicentered clinical experience

Treatment of Spasticity With Botulinum Toxin

Pharmacokinetics of Valbenazine and Its Active Metabolite by Age Group

Poster Number: NR 31 - Pharmacokinetics of Valbenazine and Its Active Metabolite by Age Group

The Estimated Cost of Managing Focal Spasticity: A Physician Practice Patterns Survey

A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia

Single Dose and Repeat Once-Daily Dose Safety, Tolerability and Pharmacokinetics of Valbenazine in Healthy Male Subjects

Injection techniques for botulinum toxin using electromyography and electrical stimulation

Treatment of spasticity with botulinum toxin: Botulinum toxin for pain management and other medical conditions: a comprehensive review

Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder

Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder

Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder

N-methyl-D-aspartate antagonists in the treatment of Parkinson's disease

Spasticity after stroke. Epidemiology and optimal treatment

Suchergebnisse filtern